These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 37521791)

  • 1. Direct Cytosolic Delivery of Proteins and CRISPR-Cas9 Genome Editing by Gemini Amphiphiles via Non-Endocytic Translocation Pathways.
    Le Z; Pan Q; He Z; Liu H; Shi Y; Liu L; Liu Z; Ping Y; Chen Y
    ACS Cent Sci; 2023 Jul; 9(7):1313-1326. PubMed ID: 37521791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the Effect of Amphiphile Architecture on Intracellular Protein Delivery Capacity: Dimeric versus Trimeric Amphiphiles.
    Chen S; Le Z; Gu J; Liu L; Liu Z; Chen Y
    ACS Appl Mater Interfaces; 2023 Jun; 15(22):26328-26339. PubMed ID: 37219911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct Cytosolic Delivery of CRISPR/Cas9-Ribonucleoprotein for Efficient Gene Editing.
    Mout R; Ray M; Yesilbag Tonga G; Lee YW; Tay T; Sasaki K; Rotello VM
    ACS Nano; 2017 Mar; 11(3):2452-2458. PubMed ID: 28129503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guanidyl-Rich Poly(β Amino Ester)s for Universal Functional Cytosolic Protein Delivery and Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Cas9 Ribonucleoprotein Based Gene Editing.
    Wang X; Li Y; Wang X; Sandoval DM; He Z; A S; Sáez IL; Wang W
    ACS Nano; 2023 Sep; 17(18):17799-17810. PubMed ID: 37669145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of CRISPR/Cas Delivery Systems for In Vivo Precision Genome Editing.
    Chen Y; Ping Y
    Acc Chem Res; 2023 Aug; 56(16):2185-2196. PubMed ID: 37525893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simple in Vivo Gene Editing via Direct Self-Assembly of Cas9 Ribonucleoprotein Complexes for Cancer Treatment.
    Kim SM; Shin SC; Kim EE; Kim SH; Park K; Oh SJ; Jang M
    ACS Nano; 2018 Aug; 12(8):7750-7760. PubMed ID: 30028587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced Cytosolic Delivery and Release of CRISPR/Cas9 by Black Phosphorus Nanosheets for Genome Editing.
    Zhou W; Cui H; Ying L; Yu XF
    Angew Chem Int Ed Engl; 2018 Aug; 57(32):10268-10272. PubMed ID: 29939484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gemini Amphiphiles: Robust Cytosolic Delivery of Therapeutic Biomacromolecules through Non-Endocytic Translocation Pathways.
    Zhao Y; Wich D; Xu Q
    ACS Cent Sci; 2023 Jul; 9(7):1266-1268. PubMed ID: 37521797
    [No Abstract]   [Full Text] [Related]  

  • 9. Integrating Combinatorial Lipid Nanoparticle and Chemically Modified Protein for Intracellular Delivery and Genome Editing.
    Chang J; Chen X; Glass Z; Gao F; Mao L; Wang M; Xu Q
    Acc Chem Res; 2019 Mar; 52(3):665-675. PubMed ID: 30586281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome editing of mutant KRAS through supramolecular polymer-mediated delivery of Cas9 ribonucleoprotein for colorectal cancer therapy.
    Wan T; Chen Y; Pan Q; Xu X; Kang Y; Gao X; Huang F; Wu C; Ping Y
    J Control Release; 2020 Jun; 322():236-247. PubMed ID: 32169537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carrier-Free Cellular Transport of CRISPR/Cas9 Ribonucleoprotein for Genome Editing by Cold Atmospheric Plasma.
    Cui H; Jiang M; Zhou W; Gao M; He R; Huang Y; Chu PK; Yu XF
    Biology (Basel); 2021 Oct; 10(10):. PubMed ID: 34681136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational Design of Poly(disulfide)s as a Universal Platform for Delivery of CRISPR-Cas9 Machineries toward Therapeutic Genome Editing.
    Guo J; Wan T; Li B; Pan Q; Xin H; Qiu Y; Ping Y
    ACS Cent Sci; 2021 Jun; 7(6):990-1000. PubMed ID: 34235260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TOP-EVs: Technology of Protein delivery through Extracellular Vesicles is a versatile platform for intracellular protein delivery.
    Ilahibaks NF; Ardisasmita AI; Xie S; Gunnarsson A; Brealey J; Vader P; de Jong OG; de Jager S; Dekker N; Peacock B; Schiffelers RM; Sluijter JPG; Lei Z
    J Control Release; 2023 Mar; 355():579-592. PubMed ID: 36746337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carboxylated branched poly(β-amino ester) nanoparticles enable robust cytosolic protein delivery and CRISPR-Cas9 gene editing.
    Rui Y; Wilson DR; Choi J; Varanasi M; Sanders K; Karlsson J; Lim M; Green JJ
    Sci Adv; 2019 Dec; 5(12):eaay3255. PubMed ID: 31840076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineering Nucleotidoproteins for Base-Pairing-Assisted Cytosolic Delivery and Genome Editing.
    Liu X; Zhao Z; Li W; Li Y; Yang Q; Liu N; Chen Y; Yin L
    Angew Chem Int Ed Engl; 2023 Nov; 62(45):e202307664. PubMed ID: 37718311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scaffold-mediated non-viral delivery platform for CRISPR/Cas9-based genome editing.
    Chin JS; Chooi WH; Wang H; Ong W; Leong KW; Chew SY
    Acta Biomater; 2019 May; 90():60-70. PubMed ID: 30978509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diosgenin enhances liposome-enabled nucleic acid delivery and CRISPR/Cas9-mediated gene editing by modulating endocytic pathways.
    Lohchania B; Christopher AC; Arjunan P; Mahalingam G; Kathirvelu D; Prasannan A; Venkatesan V; Taneja P; Km MK; Thangavel S; Marepally S
    Front Bioeng Biotechnol; 2022; 10():1031049. PubMed ID: 36698628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One-in-one individual package and delivery of CRISPR/Cas9 ribonucleoprotein using apoferritin.
    Pan X; Pei X; Huang H; Su N; Wu Z; Wu Z; Qi X
    J Control Release; 2021 Sep; 337():686-697. PubMed ID: 34389365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane-destabilizing ionizable phospholipids for organ-selective mRNA delivery and CRISPR-Cas gene editing.
    Liu S; Cheng Q; Wei T; Yu X; Johnson LT; Farbiak L; Siegwart DJ
    Nat Mater; 2021 May; 20(5):701-710. PubMed ID: 33542471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High content analysis platform for optimization of lipid mediated CRISPR-Cas9 delivery strategies in human cells.
    Steyer B; Carlson-Stevermer J; Angenent-Mari N; Khalil A; Harkness T; Saha K
    Acta Biomater; 2016 Apr; 34():143-158. PubMed ID: 26747759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.